Physician profile
James R Bailey
NPI 1245891068
$23,832.94
in general payments reported to CMS, 2019-2025
7 companies · $17K in 2025
The $17K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $103 · 2021: $394 · 2022: $568 · 2023: $455 · 2024: $5,262 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,830 · Grant: $6,667 · Travel and Lodging: $5,638 · Food and Beverage: $2,309 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,830.00 |
| Grant | $6,666.66 |
| Travel and Lodging | $5,637.98 |
| Food and Beverage | $2,308.93 |
| Education | $134.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $15,636.27 | 2021-2025 | Persona, Avenir, Rosa |
| Smith+Nephew, INC. | $6,847.13 | 2024-2025 | Real Intelligence |
| Depuy Synthes Sales INC. | $691.29 | 2019-2024 | Attune, Velys, Actis |
| Stryker Corporation | $418.98 | 2021-2024 | Actishield, Mako, Insignia |
| Orthalign INC | $113.15 | 2024 | Orthalign Plus |
| Getinge USA Sales, LLC | $103.04 | 2020 | |
| Elevate Surgical Co | $23.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.